• David Cucchiari, Juan M Pericàs, Josep Riera, Roberto Gumucio, Emmanuel Coloma Md, David Nicolás, and Hospital Clínic 4H Team.
• Renal Transplantation Unit, Nephrology Service, Hospital Clinic Barcelona, Spain.
• Med Clin (Barc). 2020 Dec 11; 155 (11): 502505502-505.

BackgroundIn the context of the COVID-19 pandemic the risk of misdiagnosis of other causes of respiratory infection is likely. In this work we aim to describe the clinical characteristics, treatment and outcome of pneumococcal infection in COVID-19 patients.Patients And MethodsEvery COVID-19 patient presenting with concomitant pneumococcal pneumonia during March 2020 in a tertiary teaching Hospital In Barcelona, Spain.ResultsFive patients with PCR confirmed COVID19 or clinical and radiological suspicion were diagnosed of pneumococcal infection. In all cases chest X-ray were abnormal, with unilateral or bilateral infiltrates. Procalcitonin showed to be not sensitive enough to detect pneumococcal infection. Antibiotherapy was promptly started in all five cases with subsequent satisfactory evolution.ConclusionInternational guidelines do not include the universal screening for bacterial co-infection. Radiological pattern of COVID-19 can be indistinguishable from that of pneumococcus pneumonia and frequency of co-infection is not well stablished, therefore clinicians should be aware of the possible SARS-CoV-2-pneumococcus association to avoid misdiagnosis and delay antibiotic therapy.Copyright © 2020 Elsevier España, S.L.U. All rights reserved.

36 keywords...

hide…